{"url":"https://lda.senate.gov/api/v1/filings/07ec0b5a-e3aa-4a5f-95ee-dfeca2784e36/","filing_uuid":"07ec0b5a-e3aa-4a5f-95ee-dfeca2784e36","filing_type":"4T","filing_type_display":"4th Quarter - Termination","filing_year":2014,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/07ec0b5a-e3aa-4a5f-95ee-dfeca2784e36/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Kimberley Fritts, CEO","dt_posted":"2015-01-20T20:38:12.877000-05:00","termination_date":"2014-12-31","registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1001 G STREET, NW","registrant_address_2":"SUITE 1000 WEST","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":31680,"url":"https://lda.senate.gov/api/v1/registrants/31680/","house_registrant_id":31110,"name":"PODESTA GROUP, INC.","description":"Public policy, government relations and public affairs firm","address_1":"1001 G Street, NW","address_2":"Suite 1000 West","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANTHONY PODESTA","contact_telephone":"+1 202-413-5027","dt_updated":"2022-04-06T16:07:38.635383-04:00"},"client":{"id":138309,"url":"https://lda.senate.gov/api/v1/clients/138309/","client_id":238,"name":"GENZYME","general_description":null,"client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-13"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Medicare/Medicaid reimbursement.\nRare disease coverage.\nFDA policy.","foreign_entity_issues":"As the ultimate parent of Genzyme Corporation, Sanofi-aventis has an interest in the issues lobbied.","lobbyists":[{"lobbyist":{"id":13123,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"PODESTA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58093,"prefix":null,"prefix_display":null,"first_name":"NORA","nickname":null,"middle_name":null,"last_name":"CONNORS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":49105,"prefix":"mr","prefix_display":"MR.","first_name":"ARANTHAN","nickname":"AJ","middle_name":null,"last_name":"JONES","suffix":"ii","suffix_display":"II"},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}